Zobrazeno 1 - 10
of 36
pro vyhledávání: '"SHOKO TAKANO"'
Autor:
Yuki Mukai, Yuichiro Hayashi, Izumi Koike, Toshiyuki Koizumi, Madoka Sugiura, Senri Oguri, Shoko Takano, Mitomu Kioi, Mizuki Sato, Kenji Mitsudo, Masaharu Hata
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background We compared outcomes and toxicities between concurrent retrograde super-selective intra-arterial chemoradiotherapy (IACRT) and concurrent systemic chemoradiotherapy (SCRT) for gingival carcinoma (GC). Methods We included 84 consec
Externí odkaz:
https://doaj.org/article/5cb94419ee2a45778b33df3f93ecb086
Autor:
Yuki Makai, Narihiko Hayashi, Izumi Koike, Hisashi Kaizu, Shoko Takano, Madoka Sugiura, Eiko Ito, Mizuki Sato, Hiroji Uemura, Masahiro Yao, Masaharu Hata
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 10, Iss 5, Pp 397-404 (2018)
Externí odkaz:
https://doaj.org/article/2739d63d08e74b61b6cd733dc23f2ed5
Autor:
EIKO ITO, ICHIRO OGINO, MADOKA SUGIURA, SHIGENOBU WATANABE, YOSHIBUMI TAYAMA, SHOKO TAKANO, MASAHARU HATA
Publikováno v:
Anticancer Research. 43:2851-2857
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be7edc989fcf4e06224d61fef4149f31
https://doi.org/10.21873/anticanres.16454
https://doi.org/10.21873/anticanres.16454
Autor:
Shoko Takano, Matsuyoshi Ogawa, Noritoshi Kobayashi, Yasushi Ichikawa, Makoto Hosono, Masaharu Hata
Publikováno v:
RADIOISOTOPES. 71:135-140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e05171e2313ffcbf7d02900c0714cc68
https://doi.org/10.3769/radioisotopes.71.135
https://doi.org/10.3769/radioisotopes.71.135
Autor:
Naoki Okubo, Shoko Takano, Yasushi Ichikawa, Noritoshi Kobayashi, Matsuyoshi Ogawa, Kenichi Ito, Motohiko Tokuhisa, Tomohiro Kaneta, Makoto Hosono, Madoka Sugiura, Daisuke Utsunomiya, Seigo Kinuya, Yuma Takeda, Masaharu Hata, Akihiro Suzuki, Tomio Inoue
Publikováno v:
Annals of Nuclear Medicine
Purpose Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTA0-Tyr3-octreotate (177Lu-DOTATATE) is one of the most reliable treatments for unresectable, progressive neuroendocrine tumors (NETs) with somatostatin receptor expression. We have, f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20f84ccd0dbf196ab839ea2500e04b29
http://europepmc.org/articles/PMC8557155
http://europepmc.org/articles/PMC8557155
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(8)
Peptide receptor radionuclide therapy(PRRT)is a pioneer drug in the rapid development of radio-theranostics, and a paradigm-shifting approach to treat neuroendocrine tumor( NET). The NETTER-1 trial for NETs of the midgut is currently the only global
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37a3dddbd55190376576a4c874f6efc4
https://pubmed.ncbi.nlm.nih.gov/36046962
https://pubmed.ncbi.nlm.nih.gov/36046962
Autor:
Takeshi Shimamura, Shoko Takano, Noritoshi Kobayashi, Naoki Okubo, Yasushi Ichikawa, Yuma Takeda, Akihiro Suzuki, Motohiko Tokuhisa, Felix Kaul, Damian Wild
Publikováno v:
Journal of Hepato-Biliary-Pancreatic Sciences. 28:727-739
Background Peptide receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs is an innovative treatment for advanced somatostatin-positive neuroendocrine tumors (NETs). PRRT cannot be performed in Japan because there is no approval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca3ec444c1936bacdb1624d50005dfb
https://doi.org/10.1002/jhbp.1014
https://doi.org/10.1002/jhbp.1014
Autor:
Takeshi Shimamura, Yukihiko Hiroshima, Ayumu Goto, Shoko Takano, Noritoshi Kobayashi, Itaru Endo, Naoki Ohkubo, Yuuma Takeda, Motohiko Tokuhisa, Yasushi Ichikawa
Publikováno v:
Suizo. 35:97-103
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33913592d5f597493d05ea5c1c3bb760
https://doi.org/10.2958/suizo.35.97
https://doi.org/10.2958/suizo.35.97
Autor:
Atsushi, Kudo, Ukihide, Tateishi, Ryoichi, Yoshimura, Junichi, Tsuchiya, Kota, Yokoyama, Shoko, Takano, Noritoshi, Kobayashi, Daisuke, Utsunomiya, Masaharu, Hata, Yasushi, Ichikawa, Minoru, Tanabe, Makoto, Hosono, Seigo, Kinuya
Publikováno v:
Journal of hepato-biliary-pancreatic sciencesREFERENCES. 29(4)
The present prospective phase 1/2 study aimed to elucidate the efficacy and safety ofFrom April 2018 to October 2020, 15 patients with advanced NETs (five midgut, eight pancreatic, and two lung NETs) were enrolled. Objective response rate (ORR), prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b596422d8654a2b983cf99fe153d4bb0
https://pubmed.ncbi.nlm.nih.gov/34907652
https://pubmed.ncbi.nlm.nih.gov/34907652
Autor:
Hideyuki Hongo, Yumiko Tayama, Hironori Nagata, Tomio Inoue, Kumiko Tanaka, Ryoko Suzuki, Masaharu Hata, Harumitsu Hashimoto, Shoko Takano, Kengo Matsui, Motoko Omura
Publikováno v:
Journal of Radiation Research
Intensity-modulated radiation therapy (IMRT) delivers an excellent dose distribution compared with conventional three-dimensional conformal radiation therapy (3D-CRT) for postoperative radiation including the lymph nodes in breast cancer patients. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe07e2169192bc47eb512b21900fc910
http://europepmc.org/articles/PMC6805983
http://europepmc.org/articles/PMC6805983